Abstracts

SHORT- AND LONG-TERM DYNAMICS OF SIV-INFECTED CELL POPULATIONS ON ART

Background: Antiretroviral therapy (ART) potently suppresses HIV-1 replication and prevents infection of new cells. Understanding changes in HIV-infected cell populations following ART initiation can inform design and evaluation of cure strategies by providing insights into the cells that enter the long-term reservoir. Recently, White et al. explored the decay kinetics of infected CD4+ T cells…

A PHASE 1B STUDY OF ZOTATIFIN FOR THE TREATMENT OF MILD TO MODERATE COVID (PROpel)

Background: Zotatifin (eFT226) is a potent and selective inhibitor of eukaryotic initiation factor 4A (eIF4A), a host RNA helicase required for SARS-CoV-2 replication. In vitro, zotatifin demonstrates broad spectrum antiviral activity against all human coronaviruses tested. Zotatifin has physicochemical and pharmacokinetic (PK) properties suitable for convenient, single subcutaneous (sc) injection. This study assessed the safety,…

SARS-CoV-2 ANTIVIRAL ACTIVITY OF ZOTATIFIN, A HOST-TARGETING eIF4A INHIBITOR

Background: Zotatifin (eFT226) is a potent and selective inhibitor of eukaryotic initiation factor 4A (eIF4A), a host RNA helicase required for SARS-CoV-2 replication. Zotatifin selectively inhibits translation of ribonucleic acids (RNAs) containing specific short polypurine motifs in their 5-prime (5’) regions. Two such highly conserved motifs are found in the SARS-CoV-2 genome. Zotatifin is currently…

COMORBIDITIES AND SYMPTOMS ASSOCIATED WITH FALLS: 2020-2021

Background: Falls are associated with aging-related decline in health, occurring more frequently among people 65 years-old and older. People with HIV (PWH) experience aging-related complications earlier than the general population. While falls have previously been associated with aging-related complications among PWH, this work is limited by small sample sizes, focused on only healthcare-reported falls, and…

INTERNALIZED HIV STIGMA AND MENTAL HEALTH/SUBSTANCE USE OVER TIME

Background: Internalized HIV stigma (IHS) may have significant impact on people with HIV (PWH). Our prior work suggests associations between IHS and increased HIV viral load are mediated by depression. Herein, we describe longitudinal changes in IHS and associations with mental health and substance use. Methods: The CFAR Network of Integrated Clinical Systems (CNICS) is…

DIFFERENTIATED SERVICE DELIVERY FOR PEOPLE COINFECTED WITH DRUG RESISTANT TB AND HIV

Background: For people living with HIV/AIDS, Differentiated Service Delivery (DSD) has focused on enhancing resilience, self-efficacy, and engagement. For people co-infected with HIV/AIDS and multidrug resistant tuberculosis (MDR-TB), particularly in subSaharan Africa, there are severe challenges associated with treatment, including stigma, social and structural barriers. We used empirical adherence data and qualitative research to identify…

WEIGHT CHANGE AFTER 48 WEEKS ON DOLUTEGRAVIR: A PROSPECTIVE STUDY OF PWH IN UGANDA

Background: Significant weight gain has been reported among people with HIV (PWH) initiating integrase inhibitor-based antiretroviral therapy (ART). We aimed to describe weight change over 48 weeks among PWH in Uganda who were transitioned from non-nucleoside reverse transcriptase inhibitor (NNRTI)-based ART to a regimen containing tenofovir, lamivudine, and dolutegravir (TLD). Methods: The DISCO cohort study…

PLASMA AND URINE PK OF DOLUTEGRAVIR AND TENOFOVIR TO AID POINT-OF-CARE TESTING

Background: Poor adherence to antiretroviral therapy and PrEP can significantly impact patient and public health. Point-of-care testing (POCT) may aid monitoring and improvement of adherence. We report the PK of dolutegravir (DTG) and tenofovir (TFV) [dosed as disoproxil fumarate (TDF)] in plasma and urine following drug cessation to evaluate missed dosing (non-adherence) and potential targets…

THE ROLE OF MYELOID-DERIVED SUPRESSOR CELLS IN STI-MEDIATED ENHANCED HIV INFECTION

Background: Sexually transmitted infections (STIs) may affect the development and pathogenesis of other STIs, such as enhanced HIV infection. Understanding the mechanisms by which STIs enhance early events in HIV acquisition and replication would allow designing preventive strategies. Myeloid-derived suppressor cells (MDSCs) are a diverse population of immature myeloid cells that may exert immune-suppressive effects…